Wilson Sonsini Goodrich & Rosati is pleased to present the 2024 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 124 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based tech and life science companies between January 1 and June 30, 2024.
Key findings include:
The report excludes data related to PIPEs by special purpose acquisition companies (SPACs) and equity lines of credit.
Click here to read the report.